Fichtenbaum, Carl J <br/><br/>
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.  [electronic resource] 

 -  AIDS (London, England)  Mar 2002 
 - 569-77 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/00002030-200203080-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anticholesteremic Agents--adverse effects<br/>Atorvastatin<br/>Drug Interactions<br/>HIV Protease Inhibitors--pharmacokinetics<br/>HIV Seronegativity<br/>Heptanoic Acids--adverse effects<br/>Human Experimentation<br/>Humans<br/>Pravastatin--adverse effects<br/>Pyrroles--adverse effects<br/>Ritonavir--pharmacokinetics<br/>Saquinavir--pharmacokinetics<br/>Simvastatin--adverse effects